KayakerBC

i don't agree with your timing for a deal being 2024 0r 2025....  Zenith might not get a full buyout deal in 2023 but I don't see why any one of the BP involved in the current ongoing  Zen3694 clinical trials couldn't do CVR milestone type deal to lock in this technology.  It could be  upfront money and then milestone payments based on the trial  results  or if Zen3694 gets FDA approval and registration It would be a win win for both parties zenith gets money for a possible IPO and any BP would  lock in this technology. Zenith has had trials for 10 years now so there quite a bit of data floating around .

we'll see what happens but I doubt a Hong kong investor of $4 million from march 31 would not have got inside look on a possible deal timing from management thus the nov 2023 warrant expiry. or maybe that investor is that desperate to take a nov 2023 expiry